“糖尿病视网膜病变的分子研究与最新进展”特刊社论
Editorial of the Special Issue "Molecular Research and Recent Advances in Diabetic Retinopathy".
作者信息
Bulum Tomislav, Tomić Martina
机构信息
Department of Diabetes and Endocrinology, Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, 10000 Zagreb, Croatia.
School of Medicine, University of Zagreb, Šalata 3, 10000 Zagreb, Croatia.
出版信息
Biomedicines. 2024 Aug 16;12(8):1879. doi: 10.3390/biomedicines12081879.
Abstract
Despite increasing awareness of diabetes and its devastating complications, it remains the most rapidly escalating global health issue [...].
摘要
尽管人们对糖尿病及其严重并发症的认识不断提高，但它仍是全球范围内迅速升级的最严重健康问题之一[……]。
相似文献
1
Editorial of the Special Issue "Molecular Research and Recent Advances in Diabetic Retinopathy".“糖尿病视网膜病变的分子研究与最新进展”特刊社论
Biomedicines. 2024 Aug 16;12(8):1879. doi: 10.3390/biomedicines12081879.
2
Comments from the Editor of the Special Issue "Clinical Research on Diabetic Complications".《糖尿病并发症临床研究》特刊编辑评论
J Clin Med. 2019 Dec 12;8(12):2193. doi: 10.3390/jcm8122193.
3
Demographics and Awareness of Diabetic Retinopathy among Diabetic Patients Attending Department of Ophthalmology at Dhulikhel Hospital.杜利凯尔医院眼科门诊糖尿病患者的糖尿病视网膜病变人口统计学特征及知晓情况
Kathmandu Univ Med J (KUMJ). 2022 Apr-Jun;20(78):183-187.
4
Long Noncoding RNAs and Mitochondrial Homeostasis in the Development of Diabetic Retinopathy.长链非编码 RNA 与线粒体稳态在糖尿病视网膜病变中的作用。
Front Endocrinol (Lausanne). 2022 Jun 6;13:915031. doi: 10.3389/fendo.2022.915031. eCollection 2022.
5
The Evaluation of Diabetic Patients' Awareness of Diabetic Retinopathy and Its Complications in the Western Region of Saudi Arabia.沙特阿拉伯西部地区糖尿病患者对糖尿病视网膜病变及其并发症的认知情况评估
Cureus. 2024 Jan 28;16(1):e53090. doi: 10.7759/cureus.53090. eCollection 2024 Jan.
6
Periodontal disease: A silent factor in the development and progression of diabetic retinopathy.牙周病：糖尿病视网膜病变发生和发展中的一个隐匿因素。
World J Diabetes. 2024 Aug 15;15(8):1672-1676. doi: 10.4239/wjd.v15.i8.1672.
7
Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.晚期糖基化终末产物（AGEs）和氧化应激在糖尿病视网膜病变中的作用。
Curr Pharm Des. 2008;14(10):962-8. doi: 10.2174/138161208784139729.
8
Therapeutic targets for altering mitochondrial dysfunction associated with diabetic retinopathy.治疗糖尿病性视网膜病变相关线粒体功能障碍的靶点。
Expert Opin Ther Targets. 2018 Mar;22(3):233-245. doi: 10.1080/14728222.2018.1439921.
9
Role of Inflammation in Diabetic Retinopathy.炎症在糖尿病视网膜病变中的作用。
Int J Mol Sci. 2018 Mar 22;19(4):942. doi: 10.3390/ijms19040942.
10
Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan.约旦2型糖尿病患者对糖尿病视网膜病变的知晓情况。
Diabetes Metab Syndr Obes. 2017 Oct 11;10:435-441. doi: 10.2147/DMSO.S140841. eCollection 2017.
本文引用的文献
1
Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study.GLP-1 激动剂和 SGLT-2 抑制剂对糖尿病视网膜病变进展的影响：一项汇总电子健康记录数据研究。
Am J Ophthalmol. 2024 Sep;265:39-47. doi: 10.1016/j.ajo.2024.04.010. Epub 2024 Apr 17.
2
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.钠-葡萄糖共转运蛋白 2 抑制剂和胰高血糖素样肽 1 受体激动剂治疗 2 型糖尿病的糖尿病视网膜病变和糖尿病黄斑水肿风险：来自全球联合数据库的真实世界数据研究。
Diabetologia. 2024 Jul;67(7):1271-1282. doi: 10.1007/s00125-024-06132-5. Epub 2024 Apr 8.
3
SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain.钠-葡萄糖协同转运蛋白2抑制剂与胰高血糖素样肽-1受体激动剂在治疗心脏、肾脏和大脑方面的比较
J Cardiovasc Dev Dis. 2023 Jul 30;10(8):322. doi: 10.3390/jcdd10080322.
4
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.全球、地区和国家 1990 年至 2021 年糖尿病负担，以及对 2050 年患病率的预测：2021 年全球疾病负担研究的系统分析。
Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22.
5
Diabetic retinopathy: Looking forward to 2030.糖尿病视网膜病变：展望 2030 年。
Front Endocrinol (Lausanne). 2023 Jan 9;13:1077669. doi: 10.3389/fendo.2022.1077669. eCollection 2022.
6
Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy.人工智能促进糖尿病视网膜病变的诊断和筛查。
Front Endocrinol (Lausanne). 2022 Sep 29;13:946915. doi: 10.3389/fendo.2022.946915. eCollection 2022.
7
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.全球糖尿病视网膜病变的患病率及 2045 年预期负担的系统评价和荟萃分析。
Ophthalmology. 2021 Nov;128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027. Epub 2021 May 1.
8
Artificial intelligence in diabetic retinopathy: A natural step to the future.人工智能在糖尿病视网膜病变中的应用：未来的必然趋势。
Indian J Ophthalmol. 2019 Jul;67(7):1004-1009. doi: 10.4103/ijo.IJO_1989_18.
9
Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.糖尿病眼病护理指南：国际眼科理事会基于资源设置的筛查、随访、转诊和治疗建议。
Ophthalmology. 2018 Oct;125(10):1608-1622. doi: 10.1016/j.ophtha.2018.04.007. Epub 2018 May 24.
10
Markedly Decreasing Incidence of Blindness in People With and Without Diabetes in Southern Germany.德国南部的糖尿病患者和非糖尿病患者的失明发生率显著下降。
Diabetes Care. 2018 Mar;41(3):478-484. doi: 10.2337/dc17-2031. Epub 2018 Jan 9.
Zotero 插件